A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report (Q33374788)

From Wikidata
Jump to navigation Jump to search
scientific article
  • A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report
edit
Language Label Description Also known as
English
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report
scientific article
  • A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report

Statements

A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report (English)
A Phase II Study of Irinotecan and Carboplatin in Advanced Non-small Cell Lung Cancer with Pharmacogenomic Analysis: Final Report (English)
0 references
0 references
Kristin L Hennenfent
Giancarlo A. Pillot
0 references
William L. Read
0 references
Kristin L. Hennenfent
0 references
Howard L. McLeod
0 references
1 November 2006
November 2006
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit